Signaling Pathway
Cugrastomig is a chimeric antibody of the IgG1??-[scFv-heavy -??]2 class, designed to target both PDCD1 and LAG3. This antibody incorporates both human and humanized components, optimizing it for enhanced specificity and efficacy in therapeutic applications that involve modulation of immune checkpoints.
重要通知：仅供研究使用。我们不向患者销售。
| Discription | Cugrastomig is a chimeric antibody of the IgG1??-[scFv-heavy -??]2 class, designed to target both PDCD1 and LAG3. This antibody incorporates both human and humanized components, optimizing it for enhanced specificity and efficacy in therapeutic applications that involve modulation of immune checkpoints. |
||
|---|---|---|---|
| Targets |
|
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2
